What Is Rapamycin?
Rapamycin is an FDA-approved drug that inhibits a protein called mTOR (mechanistic Target Of Rapamycin) — a master regulator of cell growth, metabolism, and aging. Discovered in soil bacteria on Easter Island (Rapa Nui) in 1972, it was first approved as an immunosuppressant for organ transplant patients. But over the past two decades, it has emerged as the most robustly validated longevity drug in existence — extending lifespan in every species tested: yeast, worms, flies, and mice.
📋 Simple Summary
Rapamycin is the most proven anti-aging drug we know about. It started as a medicine for transplant patients, but scientists discovered it extends lifespan in every animal tested — mice, flies, and worms. It works by calming down a switch in your cells called mTOR. When mTOR is quiet, your cells go into repair mode: cleaning out junk, fixing damage, and protecting your immune system. In people, small weekly doses have been shown to boost the immune system in older adults. Side effects like mouth sores are common but usually mild.
The detailed breakdown continues below for those who want the full science.
How It Works: The mTOR Pathway
mTOR acts like a cellular fuel gauge. When nutrients are abundant, mTOR is active — telling cells to grow, divide, and build proteins. When nutrients are scarce (as in fasting), mTOR quiets down and cells switch into maintenance and repair mode: cleaning out damaged proteins (autophagy), repairing DNA, and preserving stem cells.
Rapamycin partially inhibits mTOR, mimicking the cellular effects of calorie restriction without actually restricting calories. This triggers:
- Autophagy: The cell’s internal cleanup system — removing damaged mitochondria, misfolded proteins, and cellular junk that accumulates with age
- Reduced inflammation: Lowering the chronic, low-grade inflammation (“inflammaging”) that drives age-related disease
- Stem cell preservation: Protecting hematopoietic stem cells and improving immune function in older animals
- Senescence reduction: Decreasing the burden of senescent “zombie” cells
The Evidence
🥇 Animal Studies — The Gold Standard Data
2009 — The ITP Breakthrough (Harrison et al.)
The National Institute on Aging’s Interventions Testing Program (ITP) fed rapamycin to genetically diverse mice starting at 600 days old (equivalent to ~60 human years). Results: 14% lifespan extension in females, 9% in males. Replicated across three independent labs. Nature, 2009. PMID: 19587680
2016 — Intermittent Dosing Works Better (Arriola Apelo et al.)
Administering rapamycin intermittently (2mg/kg every 5 days, rather than daily) extended lifespan in female mice while reducing metabolic side effects. J Gerontol A Biol Sci Med Sci, 2016. PMID: 27091134
🥈 Human Data — Early but Promising
2014 — Immune Rejuvenation in the Elderly (Mannick et al.)
In a randomized, placebo-controlled trial, 6 weeks of everolimus (a rapamycin analog) improved influenza vaccine response by ~20% in elderly volunteers. It also reduced PD-1 expression on T cells — a marker of immune exhaustion that increases with age. Science Translational Medicine, 2014. PMID: 25540326
2018 — Lower Infection Rates (Mannick et al.)
A follow-up study combining everolimus with a catalytic mTOR inhibitor showed reduced infection rates in the year following treatment. PMID: 29997249
2019 — Topical Rapamycin for Skin Aging (Chung et al.)
Topical rapamycin applied to human skin reduced markers of cellular senescence and improved collagen VII expression. Geroscience, 2019. PMID: 31761958
Dosing and Safety
What We Know
- Intermittent dosing is key: Once weekly appears to capture the anti-aging benefits while minimizing side effects. Daily dosing (as used in transplant patients) causes significant immunosuppression.
- Typical off-label dose: 3-6 mg once weekly (far lower than transplant doses of 2-5 mg daily)
- Timing matters: Taking rapamycin in the evening may align better with circadian mTOR rhythms
Known Side Effects
| Side Effect | Frequency | Notes |
|---|---|---|
| Mouth ulcers (aphthous stomatitis) | Common (~25-40%) | Usually mild, dose-dependent |
| Elevated blood lipids | Common | Monitor cholesterol/triglycerides |
| Delayed wound healing | Uncommon | Stop before surgery |
| Immunosuppression | Rare at low doses | Major concern at transplant doses only |
| Increased infections | Rare at low doses | More relevant to daily high-dose use |
Important Safety Notes
- Not FDA-approved for aging or longevity — all use for this purpose is off-label
- Requires prescription — not available over the counter
- Drug interactions: Metabolized by CYP3A4 — interacts with grapefruit, antifungals, and many common medications
- Stop before surgery: Can impair wound healing
- Pregnancy/breastfeeding: Contraindicated
- Regular blood monitoring recommended: CBC, lipids, HbA1c, kidney/liver function every 3-6 months
Our Take
Rapamycin has the strongest preclinical evidence of any longevity drug — replicated lifespan extension across species and labs, with a known mechanism (mTOR inhibition) that ties directly into the biology of aging. The human data is early but directionally consistent: immune function improves, senescence markers decrease.
But — and this matters — it is not without risk. Mouth ulcers affect a significant minority of users. The long-term safety of low-dose intermittent rapamycin in healthy adults is unknown. The current evidence does not justify universal use. For those who choose to use it off-label under medical supervision, intermittent low-dose regimens (weekly, not daily) appear to be the safest approach based on current data.
🥦 Food Sources & Equivalents
The honest answer up front: ❌ Rapamycin has no food source at all — it comes from soil bacteria.
Can you get it from food?
No. Rapamycin is made by a soil bacterium called Streptomyces hygroscopicus, discovered on Easter Island (also called Rapa Nui, which is how the drug got its name). It is not found in any plant or animal food. There is no “rapamycin-rich” diet.
How much food equals the research dose?
Zero — because no food contains it. Some natural compounds (like resveratrol or spermidine) are loosely described as “mTOR inhibitors,” but none of them are rapamycin, and none match its potency or the strength of its human evidence.
The bottom line
❌ Supplement/drug only. Rapamycin is a prescription medication, not a nutrient. There is no dietary shortcut to it.
❓ Common Questions About Rapamycin
What is rapamycin?
Rapamycin is an FDA-approved drug discovered in soil bacteria on Easter Island (Rapa Nui) in 1972. It inhibits a protein called mTOR — a master regulator of cell growth, metabolism, and aging — and has emerged as the most robustly validated longevity drug in existence, extending lifespan in every species tested: yeast, worms, flies, and mice.
What does the evidence show for longevity?
The landmark 2009 ITP study showed rapamycin extended mouse lifespan by 9–14% even when started late in life (~60 human years equivalent), and this result has been replicated across three independent labs. In humans, a 2014 randomized controlled trial showed that a rapamycin analog improved influenza vaccine response by ~20% in elderly volunteers and reduced markers of immune exhaustion, while a 2018 follow-up found lower infection rates in the year following treatment.
What is the typical dose used for longevity?
Intermittent low-dose regimens (typically 3–6 mg once weekly) appear to capture anti-aging benefits while minimizing side effects, in contrast to the daily high doses (2–5 mg/day) used for transplant immunosuppression. Taking rapamycin in the evening may better align with circadian mTOR rhythms, and studies suggest intermittent dosing reduces metabolic side effects compared to daily administration.
What are the risks and side effects?
Mouth ulcers (aphthous stomatitis) are the most common side effect, affecting ~25–40% of users, though usually mild and dose-dependent. Elevated blood lipids are also common and should be monitored; while immunosuppression and increased infections are rare at low weekly doses, rapamycin can impair wound healing (so should be stopped before surgery) and interacts with grapefruit and many common medications via the CYP3A4 pathway.
Who should avoid rapamycin?
Rapamycin is contraindicated during pregnancy and breastfeeding, and anyone planning surgery should stop taking it beforehand due to impaired wound healing. It is not recommended for individuals with active infections or those taking medications metabolized by CYP3A4 without careful medical review, and regular blood monitoring (CBC, lipids, HbA1c, kidney/liver function every 3–6 months) is recommended for anyone using it off-label.
Bottom line: The science is compelling, the safety profile is manageable (but real), and we’re in the early days of translating mouse data to human protocols. Watch this space — PEARL and other ongoing trials will substantially clarify the risk/benefit balance in the next 2-3 years.
Sources
- Harrison DE et a
🦠 What This Means for Your Microbiome
Rapamycin has a complicated relationship with your gut bacteria. Unlike most longevity supplements that help the microbiome, rapamycin can actually disrupt it.
A 2026 study in Food Science & Nutrition found that rapamycin treatment significantly reduced beneficial bacteria — specifically Akkermansia muciniphila and Faecalibacterium — while increasing Desulfovibrio, a bacterial group linked to inflammation. (PMID 42491661)
This matters because:
- Akkermansia is one of the most important bacteria for metabolic health. It strengthens the gut barrier and is associated with better response to cancer immunotherapy.
- Faecalibacterium prausnitzii is a major butyrate producer — one of the most anti-inflammatory bacteria in the human gut. Losing it means less butyrate, which means more inflammation and a leakier gut.
- mTOR inhibitors as a class are known to change the gut ecosystem. A 2026 review in the Journal of Clinical Medicine confirmed that mTOR inhibitors (the drug class rapamycin belongs to) induce characteristic dysbiotic patterns — meaning they throw the gut ecosystem off balance in predictable ways. (PMID 42513562)
Is this a dealbreaker? Not necessarily. The same 2026 study found that adding chitooligosaccharides — a prebiotic fiber — alongside rapamycin helped restore the beneficial bacteria and improved outcomes. So the damage may be partially fixable with diet.
What this means for you if you take rapamycin:
- Be extra diligent about fiber intake. Aim for 30+ different plants per week.
- Consider adding fermented foods (yogurt, kefir, kimchi, sauerkraut) daily.
- If you cycle rapamycin (most people do — once weekly), your microbiome gets recovery time between doses.
- This microbiome disruption might actually be part of how rapamycin works — mTOR inhibition in gut cells and bacteria could contribute to its anti-aging effects. The science is not settled.
→ Read more about how the gut microbiome affects aging in our guide: The Microbiome Runs the Show.
l. “Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.” Nature 2009. PMID: 19587680
- Arriola Apelo SI et al. “Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice.” J Gerontol A Biol Sci Med Sci 2016. PMID: 27091134
- Mannick JB et al. “mTOR inhibition improves immune function in the elderly.” Sci Transl Med 2014. PMID: 25540326
- Mannick JB et al. “TORC1 inhibition enhances immune function and reduces infections in the elderly.” Sci Transl Med 2018. PMID: 29997249
- Chung CL et al. “Topical rapamycin reduces markers of senescence and aging in human skin.” Geroscience 2019. PMID: 31761958
- Kaeberlein M, Galvan V. “Rapamycin and Alzheimer’s disease: Time for a clinical trial?” Sci Transl Med 2019. PMID: 30674654
Disclaimer: This is an evidence review, not medical advice. Rapamycin is a prescription drug. Do not take it without medical supervision. The FDA has not approved rapamycin for aging or longevity. Full disclaimer → /disclaimer